Revenue (Quarterly) Chart

View Revenue (Quarterly) for NTRR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
April 30, 2026 0.3528M
January 31, 2026 0.2334M
October 31, 2025 0.3518M
July 31, 2025 0.2716M
April 30, 2025 0.0681M
January 31, 2025 0.001M
October 31, 2024 0.0086M
July 31, 2024 0.0262M
April 30, 2024 0.0324M
January 31, 2024 0.0281M
October 31, 2023 0.0013M
July 31, 2023 0.0043M
April 30, 2023 0.0058M
January 31, 2023 0.0059M
October 31, 2022 0.0234M
July 31, 2022 0.029M
April 30, 2022 0.0097M
January 31, 2022 0.0384M
October 31, 2021 0.0263M
July 31, 2021 0.0158M
April 30, 2021 0.0116M
January 31, 2021 0.0022M
October 31, 2020 0.0007M
July 31, 2020 0.0037M
April 30, 2020 0.003M
Date Value
January 31, 2020 0.0064M
October 31, 2019 0.00
July 31, 2019 0.00
April 30, 2019 0.00
October 31, 2018 0.00
July 31, 2018 0.00
April 30, 2018 0.002M
January 31, 2018 0.00
October 31, 2017 0.00
July 31, 2017 0.00
April 30, 2017 0.00
January 31, 2017 0.00
October 31, 2016 0.00
July 31, 2016 0.00
April 30, 2016 0.00
January 31, 2016 0.00
October 31, 2015 0.00
July 31, 2015 0.00
April 30, 2015 0.00
January 31, 2015 0.00
October 31, 2014 0.00
July 31, 2014 0.00
April 30, 2014 0.00
January 31, 2014 0.00
October 31, 2013 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Ashland, Inc. 482.00M
Achieve Life Sciences, Inc. 0.00
BioQuest Corp. 0.0825M
AJ1G, Inc. 0.0146M
Aspire Biopharma Holdings, Inc. 0.0284M